drugset / Trial / NCT02089581

A Study of Whether 2 New Oral Formulations of a Strong Pain Killer Release the Same Amount of Drug Into the Body as the Marketed Medication

NCT02089581 ↗

Phase 1 Completed 32 enrolled Mundipharma Research Limited
RandomizedCrossoverOpen-labelTreatment

Summary

To determine whether two new oral formulations of a strong pain killer release the drug into the body in a similar pattern as the already marketed reference capsule formulation with or without food.

Timeline

Start
2014-04
Primary completion
2014-05
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject MR1XXX Unknown — Oral
Comparator MR2XXX Unknown — Oral
Subject MRXXX Unknown — Oral

Indications

No indication recorded.